By December 2022 a total of 9,381 clients were active on treatment from the 32 UMMB accredited ART Sites.  96% of clients were on 1^st line ARVs while only 3.9% were on 2^nd line only one client is active on 3^rd line drugs in the network as of December 2022. Viral load suppression as of December 2022 was established at 93% from all the 21 ART sites, a total of 488 patients were being followed up and monitored as non- suppressors (viral load).